United Therapeutics buy UBS Group AG
Start price
30.06.25
/
50%
€244.10
Target price
30.06.26
€328.48
Performance (%)
-0.94%
Price
12:42
€241.80
Summary
This prediction is currently active. Since the start of the prediction for United Therapeutics the price has only changed by -0.94%. This prediction currently runs until 30.06.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | -0.94% |
| iShares Core DAX® | 2.339% |
| iShares Nasdaq 100 | 2.017% |
| iShares Nikkei 225® | 4.496% |
| iShares S&P 500 | 1.174% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at UBS Group AG from $410.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-31.94%
12:42
12:42
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-17.42%
12:42
12:42